ABRILADA

Product NDC: 50090-7998
11-digit product format: 500907998
Labeler code: 50090
Product ID: 50090-7998_fa5fba33-fd55-4011-8871-2c2013b5a0e4
Type: HUMAN PRESCRIPTION DRUG
Nonproprietary name: adalimumab-afzb
Dosage form: KIT
Labeler: A-S Medication Solutions
Application: BLA761118
Marketing category: BLA
Marketing start: 2023-12-14
Listing certified through: 2027-12-31
Current FDA listing: Yes

Additional Listing Data#

Finished product: Yes
Brand name base: ABRILADA
Listing expiration: 2027-12-31

Harmonized RxCUI identifiers#

RxCUI identifiers page 1 of 1 · 3 matching rows.

Identifier, FDA.report destination table
Identifier	FDA.report destination
797544	Internal RxNorm lookup
2668064	Internal RxNorm lookup
2668071	Internal RxNorm lookup

Harmonized SPL set identifiers#

SPL set identifiers page 1 of 1 · 1 matching rows.

Identifier, FDA.report destination table
Identifier	FDA.report destination
79943fe6-1249-4074-9aed-c53937820d0f	Available on FDA.report

openFDA label cross-check#

OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.

Matched openFDA labels page 1 of 1 · 3 matching rows.

Brand, Generic, Manufacturer table
Brand	Generic	Manufacturer	SPL set ID	Effective date	Available safety fields	Join
ABRILADA	ADALIMUMAB-AFZB	A-S Medication Solutions	1602cfaf-9ddd-4eb6-b847-10a4eebcf5e5	2026-08-07	Boxed warning, Warnings, Adverse reactions	Exact identifier application number: BLA761118
ABRILADA	ADALIMUMAB-AFZB	A-S Medication Solutions	79943fe6-1249-4074-9aed-c53937820d0f	2026-06-18	Boxed warning, Warnings, Adverse reactions	Exact identifier application number: BLA761118 ndc (product): 50090-7998
ABRILADA	ADALIMUMAB-AFZB	Pfizer Laboratories Div Pfizer Inc	5ef1c7cf-466f-495e-8d13-82e2ddfa7a4f	2026-05-06	Boxed warning, Warnings, Adverse reactions	Exact identifier application number: BLA761118

Purple Book Biologic Products#

BLA, Proprietary name, Proper name table
BLA	Proprietary name	Proper name	License type	Status	Latest source
761118	Abrilada	adalimumab-afzb	351(k) Interchangeable	Rx	2026-07-01

Packages#

Package NDC, 11-digit format, Description table
Package NDC	11-digit format	Description	Units	Marketing start	Sample	Status
50090-7998-0	50090799800	2 KIT in 1 CARTON (50090-7998-0) / 1 KIT in 1 KIT * .8 mL in 1 SYRINGE (0025-0318-01) * 1 mL in 1 PACKET (0069-1111-01)	2 kit	2026-06-17	0	Current